Chemical modification of the adeno-associated virus capsid to improve gene delivery

Archive ouverte

Mével, Mathieu | Bouzelha, Mohammed | Leray, Aurélien | Pacouret, Simon | Guilbaud, Mickaël | Penaud-Budloo, Magalie | Alvarez-Dorta, Dimitri | Dubreil, Laurence | Gouin, Sébastien | Combal, Jean, Philippe | Hommel, Mirja | Gonzalez-Aseguinolaza, Gloria | Blouin, Véronique | Moullier, Philippe | Adjali, Oumeya | Gouin, Sebastien G. | Ayuso, Eduard

Edité par CCSD ; The Royal Society of Chemistry -

International audience. Gene delivery vectors based on adeno-associated virus (AAV) are highly promising due to several desirable features of this parent virus, including a lack of pathogenicity, efficient infection of dividing and non-dividing cells and sustained maintenance of the viral genome. However, the conclusion from clinical data using these vectors is that there is a need to develop new AAVs with a higher transduction efficiency and specificity for relevant target tissues. To overcome these limitations, we chemically modified the surface of the capsid of AAV vectors. These modifications were achieved by chemical coupling of a ligand by the formation of a thiourea functionality between the amino group of the capsid proteins and the reactive isothiocyanate motif incorporated into the ligand. This strategy does not require genetic engineering of the capsid sequence. The proof of concept was first evidenced using a fluorophore (FITC). Next, we coupled the N-acetylgalactosamine ligand onto the surface of the AAV capsid for asialoglycoprotein receptor-mediated hepatocyte-targeted delivery. Chemically-modified capsids also showed reduced interactions with neutralizing antibodies. Taken together, our findings reveal the possibility of creating a specific engineered platform for targeting AAVs via chemical coupling.

Suggestions

Du même auteur

Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retina

Archive ouverte | Leray, Aurélien | CCSD

International audience. Decades of biological and clinical research have led to important advances in recombinant adeno-associated viruses rAAV-based gene therapy gene therapy. However, several challenges must be ov...

AAV-ID: A Rapid and Robust Assay for Batch-to-Batch Consistency Evaluation of AAV Preparations

Archive ouverte | Pacouret, Simon | CCSD

International audience. Adeno-associated virus (AAV) vectors are promising clinical candidates for therapeutic gene transfer, and a number of AAV-based drugs may emerge on the market over the coming years. To insure...

Mannose-coupled AAV2: a second generation AAV vector for increased retinal gene therapy efficiency

Archive ouverte | Mével, Mathieu | CCSD

Inherited retinal diseases are a leading and untreatable cause of blindness and are therefore candidate diseases for gene therapy. Recombinant vectors derived from adeno-associated virus (rAAV) are currently the most promising veh...

Chargement des enrichissements...